Effective Systolic Blood Pressure Reduction with Olmesartan Medoxomil/Amlodipine Combination Therapy: Post Hoc Analysis of Data from a Randomized, Double-Blind, Parallel-Group, Multicentre Study

Author： Mourad Jean-Jacques   >  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.29, Iss.6, 2009-05, pp. : 419-425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Tolerability of Olmesartan Medoxomil Combined with Amlodipine in Patients with Moderate to Severe Hypertension after Amlodipine Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Volpe Massimo  

Clinical Drug Investigation, Vol. 29, Iss. 1, 2009-01 ,pp. : 11-25

Adis International

Access to resources Recommend Favorite

Olmesartan Medoxomil plus Amlodipine Increases Efficacy in Patients with Moderate-to-Severe Hypertension after Monotherapy: A Randomized, Double-Blind, Parallel-Group, Multicentre Study

By Barrios Vivencio  

Clinical Drug Investigation, Vol. 29, Iss. 7, 2009-06 ,pp. : 427-439

Adis International

Access to resources Recommend Favorite

Combination Therapy with Olmesartan Medoxomil and Hydrochlorothiazide: Secondary Analysis of the Proportion of Patients Achieving Recommended Blood Pressure Goals from a Randomized, Double-Blind, Factorial Study

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 4, 2009-08 ,pp. : 241-251

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension: A Randomized, Double-Blind, Parallel-Group, Multicentre, Multinational, Phase III Study

By Fogari Roberto  

Clinical Drug Investigation, Vol. 30, Iss. 9, 2010-09 ,pp. : 581-597

Adis International

Access to resources Recommend Favorite

Triple-Combination Therapy with Olmesartan, Amlodipine, and Hydrochlorothiazide in Black and Non-Black Study Participants with Hypertension: The TRINITY Randomized, Double-Blind, 12-Week, Parallel-Group Study

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 12, Iss. 4, 2012-08 ,pp. : 233-243

Adis International

Access to resources Recommend Favorite